Using artificial intelligence to improve lung cancer detection in HIV patients in Uganda and Tanzania
Artificial Intelligence for Lung Cancer Characterization in HIV affected populations in Uganda and Tanzania
['FUNDING_OTHER'] · CASE WESTERN RESERVE UNIVERSITY · NIH-10904980
This study is looking at how to better diagnose lung cancer in people living with HIV in Uganda and Tanzania by using advanced technology to analyze chest scans, especially since tuberculosis is common in these areas.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CASE WESTERN RESERVE UNIVERSITY (nih funded) |
| Locations | 1 site (CLEVELAND, UNITED STATES) |
| Trial ID | NIH-10904980 on ClinicalTrials.gov |
What this research studies
This research investigates the rising incidence of lung cancer in Uganda and Tanzania, particularly among individuals living with HIV. It aims to develop an artificial intelligence system that enhances the accuracy of lung cancer diagnosis using chest CT scans, addressing the challenges posed by the high prevalence of tuberculosis in these regions. The study will analyze radiographic features to determine if different criteria should be applied for lung cancer screening in HIV-positive versus HIV-negative patients. By leveraging advanced imaging techniques and AI, the research seeks to improve diagnostic specificity and patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV in Uganda and Tanzania who are at risk for lung cancer.
Not a fit: Patients who do not have HIV or those who are not at risk for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of lung cancer in HIV-affected populations, ultimately improving treatment outcomes.
How similar studies have performed: While the application of AI in lung cancer detection is gaining traction globally, this specific approach targeting HIV-affected populations in East Africa is relatively novel and has not been extensively tested.
Where this research is happening
CLEVELAND, UNITED STATES
- CASE WESTERN RESERVE UNIVERSITY — CLEVELAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MADABHUSHI, ANANT — CASE WESTERN RESERVE UNIVERSITY
- Study coordinator: MADABHUSHI, ANANT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus